Last edition
News about Global Pharma
Becton Dickinson CFO Chris DelOrefice to Step Down; Vitor Roque Appointed Interim Successor
American medical technology giant Becton Dickinson and Co. (BD) has announced that Chris DelOrefice, Executive Vice President and Chief Financial Officer, will depart the company on December 5, 2025, to pursue a new professional opportunity.
Global Pharma | 16/10/2025 | By Dineshwori | 373
Viatris Acquires Aculys Pharma, Secures Exclusive Rights to Pitolisant and Spydia in Japan
Viatris has completed the acquisition of Aculys Pharma, a clinical stage biopharmaceutical company focused on commercialising innovative treatments for neurological conditions.
Global Pharma | 16/10/2025 | By Dineshwori | 277
China Approves GSK's Shingrix for Shingles Prevention
The China National Medical Products Administration (NMPA) has approved GSK’s Shingrix (Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.
Global Pharma | 15/10/2025 | By Dineshwori | 300
EY Acquires Aqurance to Boost Lifesciences Transformation on Veeva
The acquisition of Aqurance aims to strengthen the EY organisation’s Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.
Global Pharma | 15/10/2025 | By Dineshwori | 220
EVOQ Therapeutics Receives USD 2 Million NIH Grant to Develop Therapies for Celiac Disease
The NIH award represents a significant endorsement of EVOQ's ground-breaking approach to harnessing the power of the immune system to treat and prevent autoimmune diseases.
Global Pharma | 14/10/2025 | By Dineshwori | 175
Integral Molecular Launches Ready Reporter Virus Kit for 10x Faster Virus Neutralisation Testing
RRVs work by instantaneous detection of viral entry using a fluorescence-based readout. This rapid, safe and simple assay enables automatable workflows that can be performed in a standard laboratory setting.
Global Pharma | 14/10/2025 | By Dineshwori
Cumberland Pharmaceuticals Expands Vibativ Access Through Premier Group Purchasing Agreement
American specialty pharmaceutical company Cumberland Pharmaceuticals has announced that its potent antibiotic Vibativ (telavancin) has been added to a national group purchasing agreement with Premier, a leading US healthcare improvement company.
Global Pharma | 14/10/2025 | By Dineshwori | 125
South Korea's GC Biopharma Secures CMO Rights for Curevo's Shingles Vaccine
South Korean biopharmaceutical company GC Biopharma has signed a contract manufacturing agreement with Curevo Vaccine to produce amezosvatein (development name: CRV-101), a recombinant shingles vaccine currently under clinical development.
Global Pharma | 13/10/2025 | By Dineshwori | 216
The data to be presented span Merck’s broad HIV portfolio, including investigational therapies for both treatment and prevention. The presentations will feature new clinical results from Phase 1, 2, and 3 studies evaluating the efficacy, safety, and pharmacokinetics of the company’s next-generation antiviral candidates.
Global Pharma | 13/10/2025 | By Dineshwori | 175
Chugai Pharma concludes licence agreement with Roche for CT-388
Chugai Pharmaceutical has signed a licensing deal with F. Hoffmann-La Roche for CT-388, a long-acting GLP-1/GIP receptor agonist for obesity and type-II diabetes, granting Chugai exclusive development and marketing rights in Japan.
Global Pharma | 11/10/2025 | By Dineshwori | 351
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy